Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE

State Street Corp reported a 6.30% stake in Ultragenyx Pharmaceutical Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 7, 2026

State Street Corp reported a 6.30% stake in Ultragenyx Pharmaceutical Inc., 6,158,766 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).

Stake
6.30%
Shares
6,158,766
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION6.30%6,158,766

Source

View original at SEC

Related